Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STANDARD BIOTOOLS INC.LAB · Entity 6116 | Chief Financial Officer | February 21, 2023 | February 24, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STANDARD BIOTOOLS INC.
Report date February 21, 2023 · Filed February 24, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 217,622 |
Ending reported balance
After 2023-02-21 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2023-02-21 · Exercise / conversion · Acquired 50,000 · Balance 221,904 Row 2 · 2023-02-21 · Exercise / conversion · Acquired 16,666 · Balance 238,570 Row 3 · 2023-02-21 · Exercise / conversion · Acquired 2,238 · Balance 240,808 Row 4 · 2023-02-21 · Exercise / conversion · Acquired 2,391 · Balance 243,199 Row 5 · 2023-02-21 · Exercise / conversion · Acquired 3,130 · Balance 246,329 Row 6 · 2023-02-21 · Tax withholding · Disposed 28,707 · Balance 217,622 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-02-21 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2023-02-21 · Exercise / conversion · Disposed 50,000 · Balance 0 F2: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F3: The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause." |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 183,334 |
Reported balance
After 2023-02-21 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2023-02-21 · Exercise / conversion · Disposed 16,666 · Balance 183,334 F2: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F4: On December 20, 2022, the Reporting Person was granted 200,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-02-21 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2023-02-21 · Exercise / conversion · Disposed 2,238 · Balance 0 F2: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F5: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,563 |
Reported balance
After 2023-02-21 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2023-02-21 · Exercise / conversion · Disposed 2,391 · Balance 9,563 F2: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F6: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 28,176 |
Reported balance
After 2023-02-21 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2023-02-21 · Grant · Disposed 3,130 · Balance 28,176 F2: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F7: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 52,061 |
Reported balance
Holding disclosure · report date 2023-02-21 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 52,061 F1: Shares held indirectly by the Vikram and Pratima Family Trust U/A dated June 23, 2009. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held indirectly by the Vikram and Pratima Family Trust U/A dated June 23, 2009.
F2: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
F3: The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause."
F4: On December 20, 2022, the Reporting Person was granted 200,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023.
F5: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.
F6: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.
F7: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2023 Filed Feb 24, 2023 01:44 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantRestricted Stock Units · Derivative | 3,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000008 · wf-form4_167720307303910.xml · derivative · entry 12 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,176 Underlying: Common Stock · 3,130 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F7 · derivative.exercise_date: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter. F7 · derivative.expiration_date: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:44 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000008 · wf-form4_167720307303910.xml · derivative · entry 11 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,563 Underlying: Common Stock · 2,391 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F6 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F6 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:44 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,238 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000008 · wf-form4_167720307303910.xml · derivative · entry 10 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,238 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F5 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F5 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:44 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 16,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000008 · wf-form4_167720307303910.xml · derivative · entry 9 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,334 Underlying: Common Stock · 16,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F4 · derivative.exercise_date: On December 20, 2022, the Reporting Person was granted 200,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023. F4 · derivative.expiration_date: On December 20, 2022, the Reporting Person was granted 200,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:44 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000008 · wf-form4_167720307303910.xml · derivative · entry 8 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause." F3 · derivative.expiration_date: The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause." Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:44 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Tax withholdingCommon Stock | 28,707 | $2.03 | $58,275.21 |
DisclosureSEC source: 0001162194-23-000008 · wf-form4_167720307303910.xml · nonDerivative · entry 6 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,622 Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:44 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 3,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000008 · wf-form4_167720307303910.xml · nonDerivative · entry 5 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:44 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 2,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000008 · wf-form4_167720307303910.xml · nonDerivative · entry 4 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:44 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 2,238 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000008 · wf-form4_167720307303910.xml · nonDerivative · entry 3 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:44 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 16,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000008 · wf-form4_167720307303910.xml · nonDerivative · entry 2 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:44 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000008 · wf-form4_167720307303910.xml · nonDerivative · entry 1 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2022 Filed Jan 20, 2023 22:26 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantRestricted Stock Units · Derivative | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000004 · wf-form4_167425356896927.xml · derivative · entry 1 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F2 · derivative.exercise_date: The restricted stock units vest in quarterly installments over the course of four years commencing February 20, 2023. F2 · derivative.expiration_date: The restricted stock units vest in quarterly installments over the course of four years commencing February 20, 2023. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:27 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000101 · wf-form4_166915605478075.xml · derivative · entry 8 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,238 Underlying: Common Stock · 2,237 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F5 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F5 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:27 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000101 · wf-form4_166915605478075.xml · derivative · entry 7 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,954 Underlying: Common Stock · 2,391 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F4 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:27 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 3,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000101 · wf-form4_166915605478075.xml · derivative · entry 6 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,306 Underlying: Common Stock · 3,131 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F3 · derivative.exercise_date: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:27 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Tax withholdingCommon Stock | 2,681 | $1.43 | $3,833.83 |
DisclosureSEC source: 0001162194-22-000101 · wf-form4_166915605478075.xml · nonDerivative · entry 4 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,904 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:27 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 2,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000101 · wf-form4_166915605478075.xml · nonDerivative · entry 3 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:27 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 2,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000101 · wf-form4_166915605478075.xml · nonDerivative · entry 2 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:27 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 3,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000101 · wf-form4_166915605478075.xml · nonDerivative · entry 1 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:18 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000093 · wf-form4_166137591095701.xml · derivative · entry 8 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,475 Underlying: Common Stock · 2,236 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F5 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F5 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:18 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000093 · wf-form4_166137591095701.xml · derivative · entry 7 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,345 Underlying: Common Stock · 2,390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F4 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:18 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 3,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000093 · wf-form4_166137591095701.xml · derivative · entry 6 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,437 Underlying: Common Stock · 3,130 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F3 · derivative.exercise_date: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to an additional 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to an additional 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:18 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Tax withholdingCommon Stock | 2,681 | $1.56 | $4,182.36 |
DisclosureSEC source: 0001162194-22-000093 · wf-form4_166137591095701.xml · nonDerivative · entry 4 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,826 Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:18 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 2,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000093 · wf-form4_166137591095701.xml · nonDerivative · entry 3 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:18 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 2,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000093 · wf-form4_166137591095701.xml · nonDerivative · entry 2 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,271 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:18 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 3,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000093 · wf-form4_166137591095701.xml · nonDerivative · entry 1 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:15 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 12,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · derivative · entry 12 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,567 Underlying: Common Stock · 12,522 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F7 · derivative.exercise_date: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter. F7 · derivative.expiration_date: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:15 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · derivative · entry 11 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F6 · derivative.exercise_date: On May 23, 2020, the Reporting Person was granted 90,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023. F6 · derivative.expiration_date: On May 23, 2020, the Reporting Person was granted 90,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:15 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · derivative · entry 10 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,735 Underlying: Common Stock · 2,391 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F5 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F5 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:15 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · derivative · entry 9 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,711 Underlying: Common Stock · 2,237 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F4 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:15 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · derivative · entry 8 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,251 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F3 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 36,016 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 36,016 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:15 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Tax withholdingCommon Stock | 14,361 | $2.05 | $29,440.05 |
DisclosureSEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · nonDerivative · entry 6 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,751 Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:15 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 12,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · nonDerivative · entry 5 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:15 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · nonDerivative · entry 4 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,590 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:15 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 2,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · nonDerivative · entry 3 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,090 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:15 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 2,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · nonDerivative · entry 2 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,699 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2022 Filed May 24, 2022 00:15 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | Exercise / conversionCommon Stock | 2,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · nonDerivative · entry 1 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:17 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000015 · wf-form4_164574101057831.xml · derivative · entry 8 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,126 Underlying: Common Stock · 2,391 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F5 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F5 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:17 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000015 · wf-form4_164574101057831.xml · derivative · entry 7 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,948 Underlying: Common Stock · 2,237 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:17 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000015 · wf-form4_164574101057831.xml · derivative · entry 6 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,251 Underlying: Common Stock · 2,251 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 36,016 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 36,016 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:17 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 2,825 | $3.62 | $10,226.50 |
DisclosureSEC source: 0001162194-22-000015 · wf-form4_164574101057831.xml · nonDerivative · entry 4 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,211 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:17 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 2,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000015 · wf-form4_164574101057831.xml · nonDerivative · entry 3 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:17 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 2,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000015 · wf-form4_164574101057831.xml · nonDerivative · entry 2 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:17 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 2,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000015 · wf-form4_164574101057831.xml · nonDerivative · entry 1 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2022 Filed Jan 26, 2022 00:37 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000007 · wf-form4_164315743701566.xml · derivative · entry 1 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause." F2 · derivative.expiration_date: The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause." Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 23:44 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000094 · wf-form4_163779745877678.xml · derivative · entry 8 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,517 Underlying: Common Stock · 2,390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F5 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F5 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 23:44 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000094 · wf-form4_163779745877678.xml · derivative · entry 7 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,185 Underlying: Common Stock · 2,236 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 23:44 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000094 · wf-form4_163779745877678.xml · derivative · entry 6 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,502 Underlying: Common Stock · 2,251 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 36,016 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 36,016 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 23:44 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 2,378 | $4.49 | $10,677.22 |
DisclosureSEC source: 0001162194-21-000094 · wf-form4_163779745877678.xml · nonDerivative · entry 4 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,157 Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 23:44 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 2,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000094 · wf-form4_163779745877678.xml · nonDerivative · entry 3 JOG VIKRAM · CIK 0001222641 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.